Although the primary objective of reducing the proportion of subjects developing any grade @ influenza symptom or pyrexia , was not achieved , TCN-@-treated subjects showed @ % reduction ( P = @ ) in median total symptom area under the curve ( days @-@ ) and @ log reduction in median viral load area under the curve ( days @-@ ) by quantitative polymerase chain reaction ( P = @ ) compared with placebo-treated subjects .